Neurology

Subgroup analysis of genotype guided vs traditional warfarin dosing in Asian patients from an open label randomized trial

by

The Future of Anticoagulation: Beyond Warfarin and Towards Personalized Medicine For decades, warfarin has been a cornerstone of blood-thinning therapy, preventing strokes and blood clots in millions. But its notorious variability – requiring frequent blood tests and careful dose adjustments – has always been a challenge. Recent research, as highlighted by studies from BMC Med … Read more

NIH’s NINDS Director Koroshetz to Step Down, Leadership in Flux

by

NIH Leadership Shuffle: What It Means for the Future of Medical Research The impending departure of Dr. Walter Koroshetz, director of the National Institute of Neurological Disorders and Stroke (NINDS), marks a significant moment for the National Institutes of Health (NIH). With nearly half of the NIH’s 27 divisions potentially facing interim leadership, the stability … Read more

NIH neurological disorders institute director is ousted

by

NIH Leadership Shuffle: What It Means for the Future of Medical Research The impending departure of Dr. Walter Koroshetz, director of the National Institute of Neurological Disorders and Stroke (NINDS), marks a significant moment for the National Institutes of Health (NIH). With nearly half of the NIH’s 27 divisions potentially facing interim leadership, the stability … Read more

Brain-Computer Interfaces: The Surging Market & Future Tech

by

The Brain’s New Frontier: How Brain-Computer Interfaces Are Poised to Reshape Healthcare and Beyond The once-futuristic concept of directly connecting the human brain to computers is rapidly becoming a reality. Driven by recent breakthroughs and surging investment, brain-computer interface (BCI) technology is moving beyond the lab and into the lives of patients – and soon, … Read more

Self-perceived life course sleep duration trajectories and risk and age at onset of Parkinson’s disease

by

Sleep & Parkinson’s: Why Nighttime is the New Frontier Over the past decade, researchers have uncovered a striking link between sleep disturbances and the onset of Parkinson’s disease (PD). From Lajoie et al.’s review of sleep disorders in PD (2021) to large‑scale cohorts such as Fox Insight (2020‑2024), the evidence is converging on three core ideas: … Read more

How AI Could Revolutionize Migraine Diagnosis & Treatment

by

Migraines and the Future of Healthcare: How AI is Changing the Game For those who’ve experienced it, a migraine attack is far more than “just a headache.” It’s a debilitating neurological condition, marked by severe head pain, often accompanied by sensory sensitivities, nausea, and other distressing symptoms. The good news is that advances in technology, … Read more

Electronic Health Record Study Finds No Significant Cardiovascular Risk With Triptan Use for Migraine

by

Triptans and Cardiovascular Health: What’s Next for Migraine Treatment? The landscape of migraine treatment is constantly evolving. A recent study published in Migraine sheds light on the relationship between triptans, a common medication for migraine relief, and cardiovascular (CV) events. While the research offers reassuring news, it also highlights the need for a nuanced approach … Read more

A Novel Mechanism in Alzheimer Disease Treatment

by

Unlocking the Future: The Promising Frontier of Alzheimer’s Disease Immunotherapy The fight against Alzheimer’s disease (AD) is a marathon, not a sprint. With each passing year, researchers unveil new therapeutic approaches, offering a glimmer of hope for millions affected by this debilitating condition. Recent breakthroughs, like the potential of ONC-841, a monoclonal antibody targeting SIGLEC10, … Read more

Phase 3 Study Results of Obicetrapib on Alzheimer Disease Biomarker Progression: Philip Scheltens, MD, PhD

by

Obicetrapib and the Future of Alzheimer’s Treatment: A New Dawn? The medical world is buzzing with the potential of obicetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, in the fight against Alzheimer’s disease. Recent findings from the BROADWAY study, presented at the 2025 Alzheimer’s Association International Conference, suggest that this drug could be a game-changer. … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]